Investigating mono vs dual therapy for pediatric pulmonary arterial hypertension ...
The REACH Institute awards 50 cognitive behavioral therapy (CBT) scholarships to primary care clinicians nationwide to bridge critical gaps in pediatric mental health care ...
Kindergarten vaccine coverage decreased, exemptions increased in 2023-2024 school year ...
Investigating mono vs dual therapy for pediatric pulmonary arterial hypertension ...
Manufacturers who use red no. 3 in food and and ingested drugs will have until January 15, 2027 or January 18, 2028, respectively, to reformulate their products. The FDA has revoked the authorization ...
Across all years in the report, the CDC rated each physical activity trend included with a color of red, indicating that trend is going in the "wrong direction." The Youth Risk Behavior Survey (YRBS) ...
Colleen Sloan, PA-C, RDN, explores how diet can help manage childhood constipation. "She's so constipated. I give her a laxative, and she eats fruit. What else can I do?" This familiar concern echoes ...
According to the report, several key dietary behaviors such as daily fruit or vegetable intake among high school students were trending in the wrong direction. The Centers for Disease Control and ...
Of those with a minimum age or minimum interval vaccine dose, 44.9% ended up receiving extra doses to complete a vaccination series. Vaccine doses provided to children outside of the CDC's Advisory ...
The lead clinical trial investigator for a phase 3 study of crinecerfont in pediatric CAH patients breaks down the December 2024 FDA approval. The FDA approval of crinecerfont (Crenessity; Neurocrine ...
Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial assessing mono vs dual therapy for pediatric PAH. Lewis Romer, MD, ...
Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg). ARS Pharmaceuticals has announced new developments for neffy (epinephrine ...